Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00013
|
|||||
| EM Name |
N1-acetylspermidine
|
|||||
| Synonyms |
N1-Acetylspermidine; N(1)-Acetylspermidine; 1-N-Acetylspermidine; N-Acetylspermidine; N-(3-((4-Aminobutyl)amino)propyl)acetamide; CHEMBL176800; n-(3-((4-aminobutyl)amino)propyl)-acetamide; N-[3-(4-aminobutylamino)propyl]acetamide; N-{3-[(4-aminobutyl)amino]propyl}acetamide; an N-acetylspermidine; Acetamide, N-[3-[(4-aminobutyl)amino]propyl]-; Acetamide, N-(3-((4-aminobutyl)amino)propyl)-; AC1Q5PFT; SCHEMBL183048; AC1L19D7; DTXSID80162175; ZINC1532698; BDBM50405933; AKOS024183045; C00612
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=496"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C9H21N3O
|
|||||
| Canonical SMILES |
CC(=O)NCCCNCCCCN
|
|||||
| InChI |
InChI=1S/C9H21N3O/c1-9(13)12-8-4-7-11-6-3-2-5-10/h11H,2-8,10H2,1H3,(H,12,13)
|
|||||
| InChIKey |
MQTAVJHICJWXBR-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 14278-49-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 187.28 | Topological Polar Surface Area | 67.2 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17927
|
|||||
| DT(s) "handling" This EM | GC1 | Transporter Info | Mitochondrial glutamate carrier 1 | [1] | ||
| References | ||||||
| 1 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.